Medigus Revoltz Initiates on Exclusive Distribution Agreement of 2.7 Million in Revenues and Completes the Production of the First 50 PORTO Micro-Mobility EVs

MDGSDelisted Stock  USD 1.73  0.01  0.58%   
Slightly above 53% of Medigus' investor base is interested to short. The analysis of current outlook of investing in Medigus Ltd ADR suggests that many traders are impartial regarding Medigus' prospects. Medigus' investing sentiment can be driven by a variety of factors including economic data, Medigus' earnings reports, geopolitical events, and overall market trends.
  
Following completion of initial production, Revoltz sets up for delivery in accordance with its distribution agreement , aiming to sell 150 vehicles in the first year of the Agreement Tel Aviv, Israel, March 27, 2024 -- Medigus Ltd. , a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Revoltz Ltd, its EV joint venture, 19.9 percent owned by i

Read at finance.yahoo.com
Yahoo News
  

Medigus Fundamental Analysis

We analyze Medigus' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medigus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medigus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Medigus is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Medigus Ltd ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medigus stock to make a market-neutral strategy. Peer analysis of Medigus could also be used in its relative valuation, which is a method of valuing Medigus by comparing valuation metrics with similar companies.

Peers

Medigus Related Equities

NXLNexalin Technology   10.91   
0%
100.0%
DCTHDelcath Systems   5.35   
0%
49.0%
ICCMIcecure Medical   5.34   
0%
48.0%
RSLSReShape Lifesciences   3.42   
0%
31.0%
SSKNSTRATA Skin   2.36   
0%
21.0%
IRIXIRIDEX   1.69   
0%
15.0%
FNAParagon 28   0.10   
0%
1.0%
BRSYFBrainsWay   0.00   
0%
0%
SRDXSurModics   0.10   
1.0%
0%
BWAYBrainsway   0.31   
2.0%
0%
NUWENuwellis   1.43   
13.0%
0%
NSYSNortech Systems   2.07   
18.0%
0%
TNONTenon Medical   2.50   
22.0%
0%
BJDXBluejay Diagnostics   3.87   
35.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Medigus Stock

If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
CEOs Directory
Screen CEOs from public companies around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies